PCOS Facial Hair Removal in Hyderabad – My Specialised Laser + Hormone Protocol

Understanding PCOS Hirsutism

Polycystic Ovary Syndrome affects 8-13% of women of reproductive age globally, and the prevalence in Indian women is estimated at 9-36% depending on the diagnostic criteria used (Ref 1). One of the most distressing symptoms is hirsutism, which is excessive hair growth in typically male-pattern areas: upper lip, chin, jawline, sideburns, and sometimes the chest and abdomen.

The hormonal mechanism: elevated androgens (particularly testosterone and DHEA-S) convert fine vellus hair follicles into thick, dark terminal hairs. This conversion is progressive. Untreated, the hair becomes coarser and covers more area over time.

What makes PCOS hirsutism different from regular unwanted hair:

• •Hormonal stimulation is ongoing, so follicles are constantly activated.
• •Standard 6-session laser packages produce poor results because hormones recruit new follicles between sessions.
• •Without hormonal management, laser results fade faster.

My Dual-Track Protocol

I treat PCOS facial hair with a two-pronged approach:

Track 1, Dermatological (Laser + Topicals):

• •Diode laser (810nm) or Nd:YAG (1064nm): I choose based on skin tone. For Fitzpatrick IV-V (most Indian patients), Nd:YAG is safer with less risk of burns or pigmentation.
• •Treatment schedule: 6-8 sessions at 4-6 week intervals for the initial reduction, then maintenance every 3-6 months.
• •Higher fluence than standard protocols: PCOS hair has a thicker root, requiring more energy. I increase fluence progressively across sessions based on response.
• •Eflornithine cream (Vaniqa): Applied twice daily to treated areas. This enzyme inhibitor (ornithine decarboxylase) slows hair regrowth between laser sessions. A 2000 study in the New England Journal of Medicine showed eflornithine reduced facial hair growth by 58% when combined with laser (Ref 2).

Track 2, Hormonal (with gynaecologist/endocrinologist):

• •Anti-androgen therapy (spironolactone, cyproterone acetate, or combined OCPs): This reduces the hormonal stimulus driving new hair growth.
• •Metformin: If insulin resistance is present, metformin improves hormonal balance indirectly.
• •Lifestyle modifications: Weight management, exercise, and dietary changes reduce circulating androgens.

Without Track 2, Track 1 achieves only temporary results. This is why many patients tell me their previous laser "stopped working."

What to Expect Session by Session

• •Sessions 1-2: 20-30% reduction. Remaining hairs grow back finer.
• •Sessions 3-4: 40-50% reduction. Significant thinning visible.
• •Sessions 5-6: 60-70% reduction. Many patients report only sparse, fine regrowth.
• •Sessions 7-8: 70-85% reduction. Maintenance phase begins.
• •Maintenance: 1 session every 3-6 months for life (as long as PCOS is active). This is not a treatment failure. It is the nature of a hormonally driven condition.

I set realistic expectations upfront. "Permanent hair removal" in PCOS means permanent reduction, not permanent absence.

Myths

Myth 1: "PCOS hair can never be permanently reduced."

Reality: 70-85% permanent reduction is achievable with the right laser parameters and hormonal co-management. The IADVL guidelines endorse laser as first-line for PCOS hirsutism when combined with anti-androgen therapy (Ref 3).

Myth 2: "Chain clinic 6-session packages cure PCOS hair."

Reality: Standard 6-session protocols are designed for non-hormonal unwanted hair. PCOS requires 8+ sessions with higher fluence, plus maintenance. Generic packages under-treat and over-promise.

Myth 3: "Laser causes more hair growth (paradoxical hypertrichosis)."

Reality: Paradoxical hypertrichosis is rare (2-10% of cases) and more common with IPL than true laser. In PCOS patients with thick terminal hairs, the risk is minimal. Proper wavelength and fluence selection nearly eliminates this risk.

Myth 4: "Pain means it's working."

Reality: Pain should be controlled and tolerable. Modern lasers have integrated cooling systems. I use contact cooling and topical anaesthetic for sensitive areas.

Where I Practice

At CARE Hospitals, Hitech City, and Tatva Skin Clinic, Moosapet, I coordinate with endocrinologists. My priorities: blood work before starting laser, honest conversation about maintenance, adjustable protocol based on hormonal control and response.

Medical Citations: 1. Nidhi R, et al. "Prevalence of polycystic ovarian syndrome in Indian adolescents." *J Pediatr Adolesc Gynecol.* 2011;24(4):223-227. doi:10.1016/j.jpag.2011.03.002 2. Smith SR, et al. "Eflornithine cream combined with laser therapy for facial hirsutism." *N Engl J Med.* 2000;343(17):1236-1243. doi:10.1056/NEJM200010263431705 3. IADVL Task Force. "IADVL consensus on management of hirsutism in Indian women." *Indian J Dermatol Venereol Leprol.* 2020;86(5):479-490. doi:10.4103/ijdvl.IJDVL_1072_18